TOKYO - Takeda Pharmaceutical Co. said Thursday it has begun clinical trials in Japan of a COVID-19 vaccine candidate by U.S. biotech firm Moderna Inc. with an eye to distributing it in the first half of this year.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
